SelectScience
Join Free
Accelerating Science
NewsLife Sciences

QIAGEN Joins Consortium to Map Microbial Genomes in 54 Cities

QIAGEN

Project that measured pathogens in New York City subways goes global this summer

20 Jun 2016
Alex Waite
Editorial Assistant

Industry news

QIAGEN has announced a collaboration with Weill Cornell Medicine in a global study seeking insights on the prevalence of pathogens, including antimicrobial resistance, in urban environments.

Starting June 21st 2016, researchers will simultaneously collect DNA and RNA samples from high-traffic areas in subway systems, buses and parks in 54 cities around the world – expanding on a metagenomic portrait of microbes in the New York City subways published in 2015. The project will use QIAGEN sample technologies and library preparation workflows to extract and prepare genomic materials for analysis.

“Mapping the unseen genomes and epigenomes of cities across six continents is an exciting effort that illustrates the potential for metagenomics to create new insights into interactions among humans, our environment and the microbes that have an impact on our health,” said Colin Baron, Senior Director and Head of QIAGEN’s Product Management NGS Life Sciences. “QIAGEN is pleased that the scientific leaders in this international collaboration have selected our MO BIO PowerSoil® sample technology kits for sample extraction and QIAseq FX DNA library preparation kits to enable reliable next-generation sequencing.”

Dr. Christopher E. Mason, Associate Professor of Physiology and Biophysics and of Computational Genomics in Computational Biomedicine in the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al-Saud Institute for Computational Biomedicine at Weill Cornell Medicine, is principal investigator on the study, in collaboration with colleagues at other institutions and the MetaSUB Consortium, which consists of 54 member cities.

“Just as our PathoMap study created a profile of New York City’s metagenome based on mass-transit areas, the MetaSUB researchers and laboratories will work to establish a worldwide ‘DNA map’ of microbes in subways and other transit systems,” Dr. Mason said. “This five-year commitment will yield insights on antimicrobial resistance in urban areas and lead to discovery of new biosynthetic gene clusters revealing interactions of microbes and the environment. Sample preparation and library preparation powered by QIAGEN are key steps in this analysis, and we expect significant findings to emerge that can benefit both scientific understanding and the public health.”

The MetaSUB team’s collection of samples from subways and other urban sites is synchronized with today’s Global Ocean Sampling Day to provide a “genetic snapshot” of the world’s cities and oceans at the same time. In some cities such as New York, Boston and Montevideo, metagenomic data also will be generated from sewer systems and beaches and compared to findings from the other environments. The data, methods, techniques and results will all be made open to the public and free for all to use.

A related project will look at metagenomic impacts of the Olympics in Rio de Janeiro in August 2016, which MetaSub calls a “natural experiment” illustrating a global human migration event. An estimated 500,000 people from around the world will attend the Olympics in August. Sampling of RNA and DNA before, during and after the Olympics will include a search for RNA viruses such as influenza and Zika.

The MetaSUB study is a Grand Challenges Explorations winner, an initiative of the Bill & Melinda Gates Foundation that seeks to foster innovation to solve key global health and development problems. A number of public funding agencies, other foundations and companies also are supporting or partnering in the effort.

Advancing the understanding of microbiomes – complex microbial content, such as in the human gut or the environment – is currently aim of many life sciences funding initiatives in which QIAGEN technologies are being used, including the National Microbiome Initiative (NMI) announced by the White House earlier this month.


 
Cities in 32 countries are currently taking part in the MetaSUB Consortium:

Argentina (Buenos Aires), Australia (Sydney), Austria (Vienna), Brazil (Ribeirão Preto, Rio Da Janeiro, and São Paulo), Chile (Santiago), China (Beijing, Guangzhou, Hong Kong, Shanghai), Colombia (Bogota), Croatia (Zagreb), Egypt (Cairo), France (Marseille and Paris), Germany (Berlin), India (Hyderabad and New Delhi), Iran (Tehran), Italy (Rome), Japan (Sendai and Tokyo), Mexico (Mexico City), New Zealand (Auckland City), Nigeria (Ilorin and Lagos), Norway (Oslo), Portugal (Lisbon and Porto), Qatar (Doha), Russia (Moscow), Singapore (Singapore), South Africa (Johannesburg), South Korea (Seoul), Spain (Barcelona), Sweden (Stockholm), Switzerland (Zurich), Turkey (Izmir), United Kingdom (Sheffield and London), Uruguay (Montevideo), United States (Baltimore, Boston, Chicago, Denver, Fairbanks, New York City, Sacramento, San Francisco, Seattle, and Washington, DC).

Links

QIAGENCompany website

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.DNA / RNA Extraction and PurificationPurified DNA and RNA are required for numerous downstream molecular biology applications. Consequently, the importance of high-quality DNA/RNA extraction and purification equipment cannot be underestimated. Many purification kits are available and are typically optimized for nucleic acid type and source, including plasmid DNA, genomic DNA, mRNA, RNA and viral nucleic acid purification kits. Automated extraction and purification of nucleic acids can be implemented with magnetic bead separator instruments or high-throughput purification workstations. Find the best DNA/RNA extraction and purification equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.DNA SequencingDNA sequencing, such as sanger sequencing, is a biological technique that determines the precise order of nucleotide bases in a fragment or template of DNA. DNA sequencers and genetic analyzers are based on capillary electrophoresis, where labeled DNA fragments are electrophoretically separated by size as they migrate through a polymer. Find the best DNA sequencing products, including DNA sequencing kits, genomic libraries and genetic identity kits in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Gene Expression and Molecular CloningMolecular cloning is a set of techniques that utilizes vectors to transfer recombinant DNA into host cells and is an essential tool for investigating the expression of genes and proteins in bacterial or mammalian cells. A variety of vectors optimized for gene cloning and expression in a range of host organisms are available, alongside competent cells for genetic replication. Here, you can explore a range of molecular tools, high-quality genomic and cDNA libraries, premade clones, transformation and transfection reagents and mutagenesis or gene expression detection assays and expression arrays. Find the best gene expression and molecular cloning products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.RNA InterferenceRNA interference (RNAi) uses siRNA or miRNA for transcriptional silencing, gene knockdown and regulation of gene expression. RNAi requires chemical synthesis, introduction of DNA vectors into cells, an assay of RNAi effects and RNAi quantification or analysis. Consider target sequence selection, reagent preparation, controls, high specificity and effectiveness and low non-specific gene knockdown.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Animal ModelsThe use of non-human animals in experiments or behavorial observations. The research is conducted inside universities, medical schools, pharmaceutical companies, farms, defence establishments, and commercial facilities that provide animal-testing services to industry. It includes pure research such as genetics, developmental biology, behavioral studies, as well as applied research such as pharmaceutical testing in pre-clinical, before human, studies. RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Influenza

Related articles

QIAGEN Joins Consortium to Map Microbial Genomes in 54 Cities